Addus HomeCare Corporation is projected to rise to $124.69 by 2027, a +15% move from its current price of $108.21. ADUS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $106.87 | $108.28 | $109.71 | +0.07% |
| Jul 14 | $106.37 | $108.35 | $110.38 | +0.13% |
| Jul 15 | $105.99 | $108.43 | $110.91 | +0.20% |
| Jul 16 | $105.69 | $108.50 | $111.37 | +0.27% |
| Jul 17 | $105.44 | $108.57 | $111.79 | +0.33% |
| Jul 18 | $105.21 | $108.64 | $112.18 | +0.40% |
| Jul 19 | $105.01 | $108.71 | $112.54 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $105.01 | $108.71 | $112.54 | +0.46% |
| Week 2 | $104.00 | $109.22 | $114.70 | +0.93% |
| Week 3 | $103.34 | $109.73 | $116.51 | +1.40% |
| Week 4 | $102.86 | $110.23 | $118.14 | +1.87% |
| Week 5 | $102.50 | $110.75 | $119.66 | +2.34% |
| Week 6 | $102.21 | $111.26 | $121.11 | +2.82% |
| Week 7 | $101.99 | $111.78 | $122.50 | +3.30% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Addus HomeCare Corporation is a healthcare company that provides services to elderly, chronically ill, disabled persons, and individuals at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health, with Personal Care focusing on non-medical assistance with daily living activities, Hospice offering palliative and related family support, and Home Health delivering skilled nursing and therapy services. The company serves federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals.
Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
The organization is categorized within the Healthcare sector and offers a suite of in-home care solutions designed to support patients across care settings, emphasizing in-home services that help individuals maintain independence and quality of life. Its structure reflects a broad footprint across personal care, hospice, and home health offerings in the United States.
Symbolically, the company trades as Addus HomeCare Corporation (ADUS). Its focus on in-home, non-acute care positions it within a growing segment of the healthcare industry dedicated to at-home services and support.
Addus HomeCare Corporation (ADUS) is a Healthcare stock currently priced at $109.72. It has a market capitalization of $2.05B and is ranked 2035 in market size.
The price outlook reflects a long-run uptrend according to the provided forecast table, starting from a 2026 average of $109.72 and rising to significantly higher levels by 2050, with notable steps along the way through 2027–2035 and beyond to 2040 and 2050.
The forecast shows a clear path of upside across the mid-to-long term, with annual average prices expanding from the 2026 baseline toward multi-hundred dollar levels by the 2040s and into 2050. These figures represent estimates of future pricing and are not guaranteed.
A major floor 25.2% below — a decisive break under it would weaken the trend.
The nearest floor, 18.2% below — buyers have tended to step in here.
Price is pressing into resistance (1.4% away) — a breakout level to watch.
A major ceiling 14.0% above — clearing it would confirm fresh momentum.
Key ADUS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ADUS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $107.19 | Buy | $106.98 | Buy |
| MA 10 | $103.88 | Buy | $104.44 | Buy |
| MA 20 | $99.40 | Buy | $101.03 | Buy |
| MA 50 | $96.23 | Buy | $98.07 | Buy |
| MA 100 | $98.06 | Buy | $99.23 | Buy |
| MA 200 | $105.56 | Buy | $102.87 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 76.18 | Sell |
| Stoch RSI (14) | 74.29 | Neutral |
| CCI (20) | 120.74 | Buy |
| Williams %R (14) | -10.28 | Info |
| MACD (12,26,9) | 1.18 | Buy |
| ROC (12) | 12.61 | Buy |
| Bollinger %B (20,2) | 0.91 | Neutral |
| Stochastic %K (14) | 89.72 | Sell |
| TRIX (15) | 0.38 | Buy |
| Awesome (5,34) | 10.92 | Buy |
| Ultimate (7,14,28) | 85.37 | Sell |
| Momentum (10) | 11.35 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 109.45 | Sell |
| ADX (14) | 32.59 | Buy |
| ATR (14) | 1.25 | Info |
The 30-day technical picture is bullish, with RSI(14) at 80, indicating overbought conditions near the current level.
The stock is trading above both the SMA50 and SMA200, which stand at $96.05 and $105.59 respectively, suggesting a positive near-term trend momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $88.49 | $108.21 | $148.36 | 0% | Neutral | |
| $102.12 | $124.69 | $159.19 | +15% | Neutral | |
| $109.21 | $135.85 | $178.12 | +26% | Bullish | |
| $123.84 | $156.43 | $209.47 | +45% | Bullish | |
| $143.74 | $184.01 | $250.84 | +70% | Bullish | |
| $165.97 | $215.08 | $297.82 | +99% | Bullish | |
| $175.53 | $230.03 | $323.05 | +113% | Bullish | |
| $186.46 | $246.93 | $351.27 | +128% | Bullish | |
| $196.30 | $262.54 | $377.95 | +143% | Bullish | |
| $200.23 | $270.34 | $393.51 | +150% | Bullish | |
| $294.71 | $415.01 | $633.05 | +284% | Bullish | |
| $593.12 | $895.75 | $1,464.65 | +728% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $88.49 | $108.21 | $127.58 | +0.00% |
| August 2026 | $95.06 | $111.28 | $133.11 | +2.84% |
| September 2026 | $97.72 | $114.95 | $138.56 | +3.29% |
| October 2026 | $97.62 | $115.30 | $139.90 | +0.31% |
| November 2026 | $98.61 | $116.87 | $142.59 | +1.36% |
| December 2026 | $101.76 | $120.99 | $148.36 | +3.53% |
Click any year to see its month-by-month ADUS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ADUS could reach as high as $148.36, with a base case around $108.21 and support toward $88.49 — roughly 0% from $108.21. Price action looks broadly range-bound.
Expect ADUS to range from $102.12 to $159.19 through 2027. The $124.69 average target implies a +15% move from current prices. That is up +15% on the projected 2026 average. A consolidation phase looks the most probable path here.
The ADUS price prediction for 2028 points to an average of $135.85 (low $109.21, high $178.12) — a potential gain of +26% on today's $108.21. Momentum favours further upside here.
In 2029, ADUS is projected to trade between $123.84 and $209.47, averaging $156.43 — a potential gain of +45% from today's $108.21. That is up +15% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Addus HomeCare Corporation's 2030 outlook centres on $184.01, within a $143.74 to $250.84 range. That is up +18% on the projected 2029 average. That marks a +70% change versus current levels. Momentum favours further upside here.
By 2031, ADUS could reach as high as $297.82, with a base case around $215.08 and support toward $165.97 — roughly +99% from $108.21. Buyers look set to stay in control over this stretch.
Expect ADUS to range from $175.53 to $323.05 through 2032. The $230.03 average target implies a +113% move from current prices. That is up +7% on the projected 2031 average. Momentum favours further upside here.
The ADUS price prediction for 2033 points to an average of $246.93 (low $186.46, high $351.27) — a potential gain of +128% on today's $108.21. Buyers look set to stay in control over this stretch.
In 2034, ADUS is projected to trade between $196.30 and $377.95, averaging $262.54 — a potential gain of +143% from today's $108.21. That is up +6% on the projected 2033 average. Momentum favours further upside here.
Addus HomeCare Corporation's 2035 outlook centres on $270.34, within a $200.23 to $393.51 range. That is up +3% on the projected 2034 average. That marks a +150% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ADUS could reach as high as $633.05, with a base case around $415.01 and support toward $294.71 — roughly +284% from $108.21. Momentum favours further upside here.
Expect ADUS to range from $593.12 to $1,464.65 through 2050. The $895.75 average target implies a +728% move from current prices. That is up +116% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ADUS today (≈ 9.24129 ADUS) could be worth
$8,277.92
+$7,277.92 (+728%) by 2050 · US Dollar
Based on the average projected ADUS price of $895.75 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ADUSwould be worth at today's price.
$1,000 invested in ADUS on Jul 10, 2025 (≈ 8.912656 ADUS) would be worth
$964.44
-$35.56 (-3.6%) today · 0.96× · US Dollar
Based on a ADUS entry price of $112.2 vs. today's $108.21.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $105.17 | $1,028.91 | +2.9% |
| 1 month ago | $93.17 | $1,161.43 | +16.1% |
| 3 months ago | $92.21 | $1,173.52 | +17.4% |
| 6 months ago | $111.41 | $971.28 | -2.9% |
| 1 year ago | $112.2 | $964.44 | -3.6% |
| All time (5.0y) ago | $84.51 | $1,280.44 | +28.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ADUS forecast.
Our base-case forecast reaches $220.00 around 2032.
Implied market cap at $220.00: $4.11B
The multi-year forecast shows a strong uptrend with rising averages and sizable ROIs across the horizon. In 2026 the average is $109.72 with a 0% ROI and neutral sentiment, followed by 2027 with an average of $127.39 and a 16.1% ROI, still neutral in sentiment. By 2028 the average is $139.74 and the ROI climbs to 27.4% with bullish sentiment.
In 2029 the average increases to $162.07 (ROI 47.7%, bullish), then to $191.32 in 2030 (ROI 74.4%, bullish). The trajectory continues to 2031 ($224.18, ROI 104.3%), 2032 ($240.44, ROI 119.1%), 2033 ($258.45, ROI 135.6%), 2034 ($275.87, ROI 151.4%), and 2035 ($284.92, ROI 159.7%), all bullish.
Longer term, the forecast projects $441.12 average by 2040 (ROI 302%, bullish) and $962.99 average by 2050 (ROI 777.7%, bullish). These are estimates and reflect a path of substantial upside with risk and uncertainty inherent in any long-range forecast.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $191.32 with a minimum of $149.44 and a maximum of $260.82, and a 74.4% ROI with bullish sentiment. This indicates a substantial-rise scenario relative to today’s price, though these figures are not guarantees.
Forecasts show neutral in 2026 (avg $109.72) and 2027 (avg $127.39), followed by bullish momentum from 2028 onward (avg $139.74 in 2028; avg $162.07 in 2029; avg $191.32 in 2030, etc.). The sequence includes ascending ROIs (e.g., 27.4% in 2028, 47.7% in 2029, up to 777.7% by 2050). These are estimates and not guarantees.
Yes. The 2029 average is $162.07, which is above $150. The 2030 minimum is $149.44, with the 2030 maximum at $260.82, indicating upside opportunities within the forecast path.
The 30-day price range is $100.60 to $119.67.
The current price is $109.72 and the market capitalization is $2.05B. The stock is ranked 2035.
Addus HomeCare Corporation Community Discussion
0Share your Addus HomeCare Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.